Immuneering Co. (NASDAQ:IMRX) Receives $12.80 Consensus PT from Analysts
By MarketBeat News | Published on 2025-01-12T06:18:50Z
Description
Immuneering Co. (NASDAQ:IMRX – Get Free Report) has been given a consensus rating of "Hold" by the eight analysts that are presently covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell rating, three have given a hold ra…
Full Content
Immuneering Co. (NASDAQ:IMRX – Get Free Report) has been given a consensus rating of "Hold" by the eight analysts that are presently covering the firm, MarketBeat reports. One research analyst has ra… [+2781 chars]
Insights
This article highlights recent developments in the world of news. Stay informed with the latest updates on global events, technology, politics, entertainment, and more. Dive into the details to get a comprehensive understanding of this topic.
Comments
Post a Comment